Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · page 33 of 56
The slide uses an antibody diagram to annotate specific technical improvements (half-life extension and formulation).
Pitch deck · solution · present_solution · dense density
Slide locked Sign in to view
Slide schematic 7/7
image 1/1 list 4/4 table 1/1 title 1/1
Components 7
illustration bullet bullet bullet bullet kpi headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.